Datavant Seeks to Improve Data Sharing
Sydney Otomancek2021-02-26T20:00:28-05:00February 26th, 2021|Categories: Featured, Industry News|Tags: Data, HEOR, observational, research, RWE|
Datavant seeks to streamline data sharing across platforms while maintaining privacy. Datavant has recently announced partnerships with specialty hub providers, [...]
Why Are US Drugs 344% More Expensive?
Sydney Otomancek2021-02-10T13:00:43-05:00February 10th, 2021|Categories: Featured, Industry News|Tags: Data, HEOR, observational, pharma, pricing, RAND, value|
A recent study from the RAND Corporation comparing generic and brand-name drug prices in the US to those in other [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Tuesday, December 5, 2023
Sponsor: ICON
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Friday, November 10, 2023
Sponsor: OpenHealth
Cell & Gene Therapies – Beginning with the End in Mind
Thursday, November 2, 2023
Sponsor: Magnolia Market Access
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication